Werbung
Werbung
HUMA
Humacyte, Inc. Common Stock
1.17
USDGesponsert
0.00
-0.34%
09. Jan., 15:59 UTC -5
Geschlossen
Nach-Markt
1.18
+0.01
+0.77%
HUMA Ergebnisberichte
Positives Überraschungsverhältnis
HUMA übertreffen die 12 der letzten 19Schätzungen.
63%
Nächster Bericht
Datum des nächsten Berichts
26. März 2026
Estimate for Q4 25 (Revenue/ EPS)
$1.37M
/-$0.13
Implizierte Änderung von Q3 25 (Revenue/ EPS)
+81.90%
/+18.18%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/-18.75%
Humacyte, Inc. Common Stock earnings per share and revenue
On 12. Nov. 2025, HUMA reported earnings of -0.11 USD per share (EPS) for Q3 25, beating the estimate of -0.16 USD, resulting in a 31.89% surprise. Revenue reached 753.00 tausend, compared to an expected 940.78 tausend, with a -19.96% difference. The market reacted with a -2.34% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.13 USD, with revenue projected to reach 1.37 million USD, implying an increase of 18.18% EPS, and increase of 81.90% in Revenue from the last quarter.
FAQ
What were Humacyte, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Humacyte, Inc. Common Stock reported EPS of -$0.11, beating estimates by 31.89%, and revenue of $753.00K, -19.96% below expectations.
How did the market react to Humacyte, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.34%, changed from $1.28 before the earnings release to $1.25 the day after.
When is Humacyte, Inc. Common Stock expected to report next?
The next earning report is scheduled for 26. März 2026.
What are the forecasts for Humacyte, Inc. Common Stock's next earnings report?
Based on 8
analysts, Humacyte, Inc. Common Stock is expected to report EPS of -$0.13 and revenue of $1.37M for Q4 2025.
Which companies are reporting earnings today?
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung